Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
En-Do's and En-Don'ts: Navigating the rapidly evolving clinical landscape in endometrial cancer.
Journal: Gynecologic oncology
Published: June 06, 2026
Mirvetuximab Soravtansine Exposure and Incidence of Cataract Surgery.
Journal: JAMA network open
Published: May 21, 2026
Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.
Journal: Gynecologic oncology
Published: April 12, 2026
Real-world genetic testing data of ovarian cancer patients: Informing counseling and risk reduction in patients over age seventy.
Journal: Gynecologic oncology
Published: April 01, 2026
Actionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related markers.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 31, 2026
Delayed Diagnosis of Ovarian Cancer and the Association With Disease Outcomes.
Journal: JAMA network open
Published: March 27, 2026
Variations and patterns in germline and somatic testing by age in ovarian, primary peritoneal, and fallopian tube cancer patients: a descriptive analysis in a large, real-world clinical and genetic data registry.
Journal: Gynecologic oncology reports
Published: March 03, 2026
Are patient factors associated with real-world antibody-drug conjugate outcomes in gynecologic cancers?
Journal: Gynecologic oncology
Published: February 23, 2026
The role of platinum-free interval in advanced endometrial cancer treatment: A real-world study of 843 patients.
Journal: Cancer treatment and research communications
Published: January 14, 2026
Predicting platinum-resistance in advanced ovarian cancer: defining patient and disease characteristics to improve treatment approaches at initiation of treatment or earlier in the course of the disease.
Journal: Frontiers in oncology
Published: December 10, 2025
Endometrial cancer therapy in 2026.
Journal: Current opinion in obstetrics & gynecology
Published: November 19, 2025
Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263).
Journal: Gynecologic oncology
Published: August 11, 2025
Last Updated: 09/26/2026